AMG 786
/ Amgen
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
June 10, 2024
Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity
(clinicaltrials.gov)
- P1 | N=65 | Completed | Sponsor: Amgen | Recruiting ➔ Completed | Trial completion date: Jun 2024 ➔ Aug 2023 | Trial primary completion date: Jun 2024 ➔ Aug 2023
Trial completion • Trial completion date • Trial primary completion date • Genetic Disorders • Obesity
April 10, 2023
Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Amgen | Trial completion date: Oct 2023 ➔ May 2024 | Trial primary completion date: Oct 2023 ➔ May 2024
Trial completion date • Trial primary completion date • Genetic Disorders • Obesity
July 27, 2022
Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity
(clinicaltrials.gov)
- P1 | N=78 | Recruiting | Sponsor: Amgen | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
June 06, 2022
Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity
(clinicaltrials.gov)
- P1 | N=78 | Not yet recruiting | Sponsor: Amgen
New P1 trial • Genetic Disorders • Obesity
1 to 4
Of
4
Go to page
1